Profil
Said Saim formerly worked at Collegium Pharmaceutical, Inc., as Senior Director-Pharmaceutical Development from 2008 to 2013, Boehringer Ingelheim Pharmaceuticals, Inc., as Principal Scientist, Higuchi Bioscience Center, as Assistant Research Professor, and EyePoint Pharmaceuticals, Inc., as Chief Technology Officer & Senior VP from 2019 to 2024.
Dr. Saim received his graduate degree and doctorate degree from the University of Kansas.
Anciens postes connus de Said Saim
| Sociétés | Poste | Fin |
|---|---|---|
| EYEPOINT, INC. | Directeur Technique/Scientifique/R&D | 01/12/2024 |
Higuchi Bioscience Center | Corporate Officer/Principal | - |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | - |
| COLLEGIUM PHARMACEUTICAL, INC. | Corporate Officer/Principal | - |
Formation de Said Saim
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
EyePoint Pharmaceuticals, Inc.
EyePoint Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets ophthalmic pharmaceuticals | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Higuchi Bioscience Center |
















